Disparities in SGLT2 Inhibitor or Glucagon-Like Peptide 1 Receptor Agonist Initiation Among Medicare-Insured Adults With CKD in the United StatesPlain-Language Summary

Rationale & Objective: Information regarding disparities in initiating sodium/glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1RA) in patients with chronic kidney disease (CKD) is limited. We examined sociodemographic and clinical factors associated...

Descrición completa

Detalles Bibliográficos

Principais autores:	Julie Z. Zhao, Eric D. Weinhandl, Angeline M. Carlson, Wendy L. St. Peter
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2023-01-01
Series:	Kidney Medicine
Assuntos:	Chronic kidney disease (CKD) disparities glucose-lowering medications Medicare claims data type 2 diabetes
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2590059522001960
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!